Signaling Pathways - Pyruvate dehydrogenases (PDH) - angiogenesis - Inward Rectifier Potassium (Kir) Channels - VEGFR3/FLT4
清除全部
-
B5851 FG2216Target: Pyruvate dehydrogenases (PDH)Summary: HIF-脯氨酰羟化酶抑制剂 -
B2198 Nateglinide中文名: 那格列奈Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 胰岛素促分泌剂 -
B2195 Gliclazide中文名: 格列齐特Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 钾通道抑制剂 -
B2193 Mitiglinide Calcium中文名: 米格列奈钙Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 钾通道抑制剂 -
B1296 Glibenclamide中文名: 格列本脲Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 胰岛素生产调节剂 -
A8534 Terfenadine中文名: 特非那定Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) ChannelsSummary: 组胺H1受体拮抗剂 -
A4333 CPI-6131 CitationTarget: Pyruvate dehydrogenases (PDH)Summary: PDH/α-KGDH抑制剂 -
A4211 Lenalidomide (CC-5013)中文名: 来那度胺Target: angiogenesisSummary: 抗肿瘤药物，抑制血管生成。 -
A4033 Glimepiride中文名: 格列美脲Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 磺酰脲类化合物 -
A4130 ENMD-2076Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-FmsSummary: Aurora A/Flt3的选择性抑制剂